{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:21:08Z","timestamp":1773303668683,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6166,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,9]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>The pathophysiological significance of ATP\u2010sensitive K<jats:sup>+<\/jats:sup>(K<jats:sub>ATP<\/jats:sub>) channels in the central nervous system is not fully understood. In this study the effects of nicorandil (a hybrid vasodilator having a dual mechanism of action as a K<jats:sup>+<\/jats:sup>channel opener and a nitrate) on the recovery of the spinal cord reflex potentials after spinal cord ischaemia were examined and compared with those of pinacidil and nitroprusside in anaesthetized spinal cats<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Spinal cord ischaemia was produced by occlusion of the thoracic aorta and the bilateral internal mammary arteries for 10 min. Regional blood flow in the spinal cord was continuously measured with a laser\u2010Doppler flow meter. The monosynaptic (MSR) and polysynaptic reflex (PSR) potentials, elicited by electrical stimulation of the tibial nerve, were recorded from the lumbo\u2010sacral ventral root. The recovery process of spinal reflex potentials was reproducible when the occlusion was repeated twice at an interval of 120 min<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Pretreatment with nicorandil (30\u2013100 \u03bcg kg<jats:sup>\u22121<\/jats:sup>) accelerated the recovery of PSR potentials after spinal cord ischaemia. Such an accelerating effect on the recovery of PSR potentials was also shared by pinacidil (100 \u03bcg kg<jats:sup>\u22121<\/jats:sup>), another K<jats:sup>+<\/jats:sup>channel opener. In addition, the accelerating effect of nicorandil (100 \u03bcg kg<jats:sup>\u22121<\/jats:sup>) on the recovery of PSR potentials was abolished by co\u2010administration of glibenclamide (3 mg kg<jats:sup>\u22121<\/jats:sup>), a sulphonylurea K<jats:sub>ATP<\/jats:sub>channel blocker. Nitroprusside (8 \u03bcg kg<jats:sup>\u22121<\/jats:sup>min<jats:sup>\u22121<\/jats:sup>) retarded rather than improved the recovery of PSR potentials after spinal cord ischaemia. AH of these drugs failed to improve the spinal cord blood flow during ischaemia and reperfusion<\/jats:p><\/jats:list-item><jats:list-item><jats:p>These results suggest that nicorandil promotes the recovery of polysynaptic reflex potentials after spinal cord ischaemia by opening the K<jats:sub>ATP<\/jats:sub>channels of neurones rather than by increasing local blood flow. K<jats:sup>+<\/jats:sup>channel openers may exert a salutary effect on the functional recovery of the ischaemic spinal cord.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1995.tb16668.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T10:55:20Z","timestamp":1342781720000},"page":"1815-1820","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of nicorandil on the recovery of reflex potentials after spinal cord ischaemia in cats"],"prefix":"10.1111","volume":"116","author":[{"given":"Toshio","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Sekikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuharu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideshige","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruaki","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0031-6997(25)06667-0","article-title":"Organic nitrate esters: clinical use and mechanisms of actions","volume":"43","author":"AHLNER J.","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2305257"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.11.030188.000525"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582512"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199220050-00012"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582258"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(90)90191-6"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.24.9816"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.69.3.571"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91141-3"},{"key":"e_1_2_1_12_1","first-page":"64","article-title":"Experimental spinal cord trauma, II: Blood flow, tissue oxygen, evoked potentials in both paretic and plegic monkeys","volume":"10","author":"DUCKER T.B.","year":"1978","journal-title":"Surg. Neurol."},{"key":"e_1_2_1_13_1","first-page":"60","article-title":"Experimental spinal cord trauma, I: Correlation of blood flow, tissue oxygen and neurologic status in the dog","volume":"10","author":"DUCKER T.B.","year":"1978","journal-title":"Surg. Neurol."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.33.040193.003121"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.3.692"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198711000-00007"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199005000-00003"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb04551.x"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp019060"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.11.1709"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13758.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198405000-00024"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199101000-00006"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3565(25)23101-9","article-title":"High affinity [3H] glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristics","volume":"256","author":"MILLER J.A.","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91288-2"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90057-I"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.15.6.577"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00231456"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1991.tb12294.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/305147a0"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90862-K"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90702-R"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00595682"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.9.3489"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/316736a0"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2501869"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.68.423"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90200-2"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91689-E"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91383-8"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb16668.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb16668.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:06:43Z","timestamp":1743811603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb16668.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb16668.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16668.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}